← 產業報告目錄

Veterinary Diagnostics Market by Technology (PCR, ELISA, Lateral Flow Assay, Molecular Diagnostics, Immunodiagnostics), Product (Consumables, Instruments), Animal (Companion, Livestock, Swine), Application (Infectious, Bacteria) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-08-08頁數 585報告編號 MD2411

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global veterinary diagnostics market is projected to reach USD 5.36 billion by 2030 from USD 3.68 billion in 2025, at a CAGR of 7.8% during the forecast period. A key growth driver for market growth includes rising ownership and the domestication of animals, particularly in urban and high-income regions. Pet owners require high-quality animal medical care, including preventive diagnostics, routine health screenings, and disease monitoring. The increasing prevalence of zoonotic diseases, such as avian influenza, leptospirosis, brucellosis, and rabies, also contributes to the market's growth. Technological advancements in real-time PCR, next-generation sequencing (NGS), microfluidics, portable diagnostic analyzers, and artificial intelligence are enhancing the accuracy, speed, and accessibility of diagnostic testing. By product, the instruments segment is projected to grow at the highest CAGR during the forecast period. By product, the market is segmented into consumables and instruments. The instruments segment is projected to grow at the highest CAGR during the forecast period. The instruments include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Increasing technological advancements and the development of AI-enabled instruments for veterinary diagnostics are expected to fuel the market adoption in this segment during the forecast period. By technology, the molecular diagnostics segment is estimated to grow at the highest CAGR during the forecast period. By technology, the molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This segment includes PCR tests, microarray tests, and nucleic acid sequencing technologies. The high growth rate of this segment is attributed to the increasing incidence of infectious and zoonotic diseases, which further increases the demand for precise and rapid diagnostic solutions. Molecular diagnostics allow the identification of specific pathogens, genetic disorders, and antimicrobial resistance, which is critical for the timely treatment of various diseases. Technological advancements in molecular diagnostic tests, such as PCR and next-generation sequencing, also contribute to the market's growth. By region, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period owing to the rising awareness about animal health, the increasing per capita income, favorable government initiatives for pet adoption, and the increasing production of livestock products in emerging economies. The rising pet ownership in rapidly urbanizing economies such as China, India, Indonesia, and South Korea is also expected to drive the market growth during the forecast period. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%) • By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%) • By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Breakdown of demand-side primary interviews: • By Company Type: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%) • By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%) • By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Research Coverage: The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential across different segments by product, application, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers:  Analysis of key drivers (rise in companion animals, growing demand for products derived from animals, increased zoonotic disease cases, increase in pet insurance, increase in disease control and disease prevention measures), restraints (rising pet cost care and high cost of diagnostic tests), opportunities (high growth potential of emerging economies), and challenges (lack of animal health awareness and shortage of veterinary practitioners) influencing the growth of the veterinary diagnostics market • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by product, application, technology, animal type, end user, and region. • Product Enhancement/Innovation: Detailed insights into upcoming trends and product launches in the global veterinary diagnostics market. • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, animal type, application, end user, and region. • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global veterinary diagnostics market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global veterinary diagnostics market.
目錄 Table of Contents
1 INTRODUCTION 47 1.1 STUDY OBJECTIVES 47 1.2 MARKET DEFINITION 47 1.2.1 INCLUSIONS & EXCLUSIONS 47 1.2.2 MARKETS & REGIONS COVERED 48 1.2.3 YEARS CONSIDERED 49 1.3 MARKET STAKEHOLDERS 49 1.4 LIMITATIONS 49 1.5 SUMMARY OF CHANGES 50 2 RESEARCH METHODOLOGY 51 2.1 RESEARCH APPROACH 51 2.2 RESEARCH METHODOLOGY DESIGN 51 2.2.1 SECONDARY RESEARCH 52 2.2.1.1 Key data from secondary sources 53 2.2.2 PRIMARY DATA 53 2.2.2.1 Key data from primary sources 54 2.2.2.2 Key industry insights 55 2.3 MARKET SIZE ESTIMATION 56 2.3.1 BOTTOM-UP APPROACH 62 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 63 2.5 MARKET SHARE ANALYSIS 64 2.6 RESEARCH ASSUMPTIONS 64 2.6.1 GROWTH RATE ASSUMPTIONS 64 2.7 RISK ASSESSMENT 65 2.8 RESEARCH LIMITATIONS 65 2.8.1 METHODOLOGY-RELATED LIMITATIONS 65 2.8.2 SCOPE-RELATED LIMITATIONS 65 3 EXECUTIVE SUMMARY 66 4 PREMIUM INSIGHTS 71 4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW 71 4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024) 72 4.3 VETERINARY DIAGNOSTICS MARKET: REGIONAL MIX 73 4.4 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 73 4.5 VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 74 5 MARKET OVERVIEW 75 5.1 MARKET DYNAMICS 75 5.1.1 DRIVERS 76 5.1.1.1 Growth in companion animal population 76 5.1.1.2 Increasing demand for animal-derived food products 78 5.1.1.3 Growing concerns about infectious zoonotic diseases 78 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure 80 5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets 82 5.1.1.6 Growing focus on disease control & prevention measures 83 5.1.2 RESTRAINTS 83 5.1.2.1 Rising pet care costs 83 5.1.2.2 High cost of veterinary diagnostic tests 84 5.1.3 OPPORTUNITIES 84 5.1.3.1 Growth potential of emerging economies 84 5.1.3.2 Integration of AI & ML 85 5.1.4 CHALLENGES 85 5.1.4.1 Low animal healthcare awareness in emerging countries 85 5.1.4.2 Shortage of veterinary practitioners in emerging economies 86 5.2 INDUSTRY TRENDS 87 5.2.1 ADOPTION OF MULTIPLE TEST PANELS 87 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 87 5.2.3 GROWING SCALE OF VETERINARY BUSINESSES 88 5.3 TECHNOLOGY ANALYSIS 88 5.3.1 KEY TECHNOLOGIES 88 5.3.1.1 Portable instruments for POC diagnostic services 88 5.3.1.2 Biosensor-based diagnostic systems 89 5.3.2 ADJACENT TECHNOLOGIES 89 5.3.2.1 Wearable biosensors & remote monitoring devices 89 5.3.2.2 Development of rapid & sensitive veterinary diagnostic kits 90 5.3.2.3 Breath & saliva-based diagnostic tools 90 5.3.2.4 Microfluidics & Lab-on-chip devices 90 5.3.3 COMPLEMENTARY TECHNOLOGIES 91 5.3.3.1 AI-driven diagnostic platforms 91 5.3.3.2 Next-generation Sequencing (NGS) 91 5.4 PORTER’S FIVE FORCES ANALYSIS 92 5.4.1 THREAT OF NEW ENTRANTS 93 5.4.2 THREAT OF SUBSTITUTES 94 5.4.3 BARGAINING POWER OF SUPPLIERS 94 5.4.4 BARGAINING POWER OF BUYERS 94 5.4.5 INTENSITY OF COMPETITIVE RIVALRY 94 5.5 REGULATORY LANDSCAPE 95 5.5.1 REGULATORY ANALYSIS 95 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 5.5.2.1 North America 95 5.5.2.2 Europe 96 5.5.2.3 Rest of the world 97 5.6 PATENT ANALYSIS 97 5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 97 5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS 98 5.7 TRADE ANALYSIS 100 5.7.1 TRADE DATA FOR HS CODE 9018 101 5.7.1.1 Import data for HS Code 9018 101 5.7.1.2 Export data for HS Code 9018 101 5.8 PRICING ANALYSIS 102 5.8.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2024 102 5.8.1.1 Average selling price trend of key players, by product, 2022–2024 102 5.8.2 AVERAGE SELLING PRICE, BY REGION 103 5.8.2.1 Average selling price of clinical chemistry analyzers and blood gas & electrolyte analyzers, by region, 2024 104 5.8.2.2 Average selling price trend of clinical chemistry reagent clips & cartridges, by region, 2022–2024 104 5.8.2.3 Average selling price trend of clinical chemistry analyzers, by region, 2022–2024 105 5.8.2.4 Average selling price trend of blood glucose strips, by region, 2022–2024 105 5.8.2.5 Average selling price trend of glucose monitors, by region, 2022–2024 105 5.8.2.6 Average selling price trend of blood gas & electrolyte reagent clips/cartridges, by region 106 5.8.2.7 Average selling price trend of blood gas & electrolyte analyzers, by region, 2022–2024 106 5.9 REIMBURSEMENT ANALYSIS 106 5.10 KEY CONFERENCES & EVENTS, 2025–2026 107 5.11 KEY STAKEHOLDERS & BUYING CRITERIA 108 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 108 5.11.2 BUYING CRITERIA 109 5.12 END-USER PERSPECTIVE & UNMET NEEDS 110 5.13 IMPACT OF AI ON VETERINARY DIAGNOSTICS MARKET 110 5.13.1 INTRODUCTION 110 5.13.2 MARKET POTENTIAL IN VETERINARY DIAGNOSTICS ECOSYSTEM 110 5.13.3 AI-USE CASES 111 5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS 111   5.14 ECOSYSTEM/MARKET MAP 112 5.15 VALUE CHAIN ANALYSIS 113 5.16 SUPPLY CHAIN ANALYSIS 114 5.17 ADJACENT MARKETS 116 5.18 INVESTMENT & FUNDING SCENARIO 116 5.19 TRUMP TARIFF IMPACT ON VETERINARY DIAGNOSTICS MARKET 117 5.19.1 INTRODUCTION 117 5.19.2 KEY TARIFF RATES 118 5.19.3 PRICE IMPACT ANALYSIS 119 5.19.4 IMPACT ON COUNTRY/REGION 120 5.19.5 IMPACT ON END-USE INDUSTRIES 122 6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT 123 6.1 INTRODUCTION 124 6.2 CONSUMABLES 126 6.2.1 RECURRING NATURE TO BOOST DEMAND 126 6.3 INSTRUMENTS 128 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET 128 7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY 130 7.1 INTRODUCTION 131 7.2 IMMUNODIAGNOSTICS 131 7.2.1 LATERAL FLOW ASSAYS 135 7.2.1.1 Lateral flow rapid tests 137 7.2.1.1.1 Ability to provide real-time insights to drive market 137 7.2.1.2 Lateral flow strip readers 139 7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption 139 7.2.2 ELISA 141 7.2.2.1 Cost-effectiveness and ease of use to drive market 141 7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 143 7.2.3.1 Increasing incidence of allergies in companion animals to fuel market 143 7.2.4 IMMUNOASSAY ANALYZERS 145 7.2.4.1 High sensitivity & specificity for biomarker detection to drive market 145 7.2.5 RADIOIMMUNOASSAYS 147 7.2.5.1 Measurement of hormone levels and detection of specific proteins to fuel market 147 7.2.6 OTHER IMMUNODIAGNOSTIC PRODUCTS 149 7.3 CLINICAL BIOCHEMISTRY 151 7.3.1 CLINICAL CHEMISTRY ANALYSIS 153 7.3.1.1 Clinical chemistry reagent clips & cartridges 156 7.3.1.1.1 Rising number of screening tests to fuel market 156 7.3.1.2 Clinical chemistry analyzers 157 7.3.1.2.1 Increasing installation of clinical chemistry analyzers to propel market 157 7.3.2 GLUCOSE MONITORING 160 7.3.2.1 Blood glucose strips 161 7.3.2.1.1 Growing demand in home care settings to fuel market 161 7.3.2.2 Glucose monitors 163 7.3.2.2.1 Growing incidence of diabetes in pet animals to fuel adoption 163 7.3.2.3 Urine glucose strips 166 7.3.2.3.1 Increasing risk of DKA in animals to propel market 166 7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS 168 7.3.3.1 Blood gas & electrolyte reagent clips & cartridges 170 7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market 170 7.3.3.2 Blood gas & electrolyte analyzers 171 7.3.3.2.1 Determination of blood oxygen & carbon dioxide levels to drive market 171 7.4 MOLECULAR DIAGNOSTICS 174 7.4.1 PCR TESTS 177 7.4.1.1 Increased laboratory usage in proteomics & genomics to support growth 177 7.4.2 MICROARRAYS 179 7.4.2.1 Growing applications of biochips in identifying infectious diseases to drive market 179 7.4.3 NUCLEIC ACID SEQUENCING 181 7.4.3.1 Identification of pathogens to fuel market 181 7.4.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 183 7.5 HEMATOLOGY 185 7.5.1 HEMATOLOGY CARTRIDGES 188 7.5.1.1 Complete blood analysis capabilities to fuel market 188 7.5.2 HEMATOLOGY ANALYZERS 189 7.5.2.1 Adoption by veterinary hospitals & clinics to support market growth 189 7.6 URINALYSIS 192 7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS 194 7.6.1.1 Detection of electrolytes to boost adoption 194 7.6.2 URINE ANALYZERS 196 7.6.2.1 Development of advanced analyzers for POC testing to support market growth 196 7.6.3 URINE TEST STRIPS 198 7.6.3.1 Increasing prevalence of CKD in cats & dogs to drive market 198 7.7 OTHER TECHNOLOGIES 200   8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE 202 8.1 INTRODUCTION 203 8.2 COMPANION ANIMALS 203 8.2.1 DOGS 206 8.2.1.1 High insurance coverage and availability of reimbursements to drive market 206 8.2.2 CATS 208 8.2.2.1 Increasing pet cat population to support market uptake 208 8.2.3 HORSES 210 8.2.3.1 Growing awareness regarding equine health to fuel market 210 8.2.4 OTHER COMPANION ANIMALS 212 8.3 LIVESTOCK 214 8.3.1 CATTLE 217 8.3.1.1 Growing consumption of dairy products to drive market 217 8.3.2 PIGS 219 8.3.2.1 Increasing incidence of infectious diseases to fuel market 219 8.3.3 POULTRY 221 8.3.3.1 Increasing demand for poultry meat contributes to market growth 221 8.3.4 OTHER LIVESTOCK ANIMALS 223 9 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION 225 9.1 INTRODUCTION 226 9.2 INFECTIOUS DISEASES 226 9.2.1 BACTERIAL INFECTIONS 229 9.2.1.1 Rapid spread of E. Coli to drive market 229 9.2.2 VIRAL INFECTIONS 231 9.2.2.1 High mutation rate to ensure continued demand for diagnostics 231 9.2.3 PARASITIC INFECTIONS 233 9.2.3.1 Presence of parasitic infections to fuel market 233 9.2.4 OTHER INFECTIONS 235 9.3 ENDOCRINOLOGY 237 9.3.1 GROWING RISK OF DIABETES TO BOOST DEMAND 237 9.4 CARDIOLOGY 239 9.4.1 INCREASING CASES OF CVD IN DOGS TO FUEL MARKET 239 9.5 ONCOLOGY 241 9.5.1 HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET 241 9.6 OTHER APPLICATIONS 243   10 VETERINARY DIAGNOSTICS MARKET, BY END USER 245 10.1 INTRODUCTION 246 10.2 VETERINARY REFERENCE LABORATORIES 246 10.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET 246 10.3 VETERINARY HOSPITALS & CLINICS 248 10.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET 248 10.4 POINT-OF-CARE/IN-HOUSE TESTING 250 10.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND 250 10.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 252 10.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH 252 11 VETERINARY DIAGNOSTICS MARKET, BY REGION 254 11.1 INTRODUCTION 255 11.2 NORTH AMERICA 256 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 256 11.2.2 US 264 11.2.2.1 High veterinary healthcare expenditure to drive market 264 11.2.3 CANADA 271 11.2.3.1 Growing pet adoption to drive market 271 11.3 EUROPE 277 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 278 11.3.2 GERMANY 285 11.3.2.1 Rising awareness of zoonotic diseases to fuel market 285 11.3.3 UK 292 11.3.3.1 Increasing pet ownership to drive market 292 11.3.4 FRANCE 299 11.3.4.1 Willingness of pet owners to spend on pet health to drive market 299 11.3.5 ITALY 306 11.3.5.1 Growing consumption of meat & dairy products to drive market 306 11.3.6 SPAIN 313 11.3.6.1 Growing demand for poultry products to fuel market 313 11.3.7 NETHERLANDS 319 11.3.7.1 Developments in veterinary diagnostic products to support market growth 319 11.3.8 REST OF EUROPE 326 11.4 ASIA PACIFIC 333 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 334 11.4.2 CHINA 342 11.4.2.1 Increasing incidence of zoonotic diseases to propel market 342 11.4.3 JAPAN 349 11.4.3.1 Increasing pet expenditure to support market growth 349 11.4.4 INDIA 357 11.4.4.1 Increasing demand for dairy products to drive market 357 11.4.5 AUSTRALIA 365 11.4.5.1 Rise in pet ownership to support market growth 365 11.4.6 SOUTH KOREA 372 11.4.6.1 Rising need for specialized veterinary services to drive market 372 11.4.7 NEW ZEALAND 379 11.4.7.1 Focus on pet insurance to aid market 379 11.4.8 VIETNAM 386 11.4.8.1 Growing focus on disease surveillance to drive market 386 11.4.9 REST OF ASIA PACIFIC 393 11.5 LATIN AMERICA 399 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 400 11.5.2 BRAZIL 407 11.5.2.1 Growth in livestock industry to boost demand 407 11.5.3 MEXICO 414 11.5.3.1 Increasing focus on poultry-associated products to support market growth 414 11.5.4 REST OF LATIN AMERICA 421 11.6 MIDDLE EAST & AFRICA 428 11.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA 429 11.6.2 GCC COUNTRIES 436 11.6.2.1 Kingdom of Saudi Arabia (KSA) 443 11.6.2.1.1 Technology advancements in veterinary diagnostics to boost demand 443 11.6.2.2 United Arab Emirates (UAE) 450 11.6.2.2.1 Favorable government support for vet diagnostics to drive market 450 11.6.2.3 Other GCC Countries 457 11.6.3 REST OF MIDDLE EAST & AFRICA 464 12 COMPETITIVE LANDSCAPE 472 12.1 OVERVIEW 472 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 472 12.3 REVENUE ANALYSIS, 2020–2024 474 12.4 MARKET SHARE ANALYSIS 474 12.4.1 RANKING OF KEY MARKET PLAYERS 476 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 477 12.5.1 STARS 477 12.5.2 EMERGING LEADERS 478 12.5.3 PERVASIVE PLAYERS 478 12.5.4 PARTICIPANTS 478   12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 479 12.5.5.1 Company footprint 479 12.5.5.2 Region footprint 480 12.5.5.3 Product footprint 481 12.5.5.4 Technology footprint 482 12.5.5.5 Animal type footprint 483 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 484 12.6.1 PROGRESSIVE COMPANIES 484 12.6.2 RESPONSIVE COMPANIES 484 12.6.3 DYNAMIC COMPANIES 484 12.6.4 STARTING BLOCKS 484 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 486 12.6.5.1 Detailed list of key startups/SMEs 486 12.6.5.2 Competitive benchmarking of key startups 487 12.7 BRAND/PRODUCT COMPARATIVE ANALYSIS 488 12.8 R&D EXPENDITURE OF KEY PLAYERS 489 12.9 COMPANY VALUATION & FINANCIAL METRICS 489 12.9.1 FINANCIAL METRICS 489 12.9.2 COMPANY VALUATION 490 12.10 COMPETITIVE SCENARIO 490 12.10.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS 490 12.10.2 DEALS 492 12.10.3 EXPANSIONS 492 12.10.4 OTHER DEVELOPMENTS 493 13 COMPANY PROFILES 494 13.1 KEY PLAYERS 494 13.1.1 IDEXX LABORATORIES, INC. 494 13.1.1.1 Business overview 494 13.1.1.2 Products/Services offered 495 13.1.1.3 Recent developments 500 13.1.1.3.1 Product/Service launches, enhancements, and approvals 500 13.1.1.4 MnM view 501 13.1.1.4.1 Key strengths 501 13.1.1.4.2 Strategic choices 501 13.1.1.4.3 Weaknesses & competitive threats 502 13.1.2 ZOETIS SERVICES LLC 503 13.1.2.1 Business overview 503 13.1.2.2 Products/Services offered 504 13.1.2.3 Recent developments 506 13.1.2.3.1 Product/Service launches, enhancements, and approvals 506 13.1.2.3.2 Deals 507 13.1.2.3.3 Expansions 507 13.1.2.4 MnM view 507 13.1.2.4.1 Key strengths 507 13.1.2.4.2 Strategic choices 508 13.1.2.4.3 Weaknesses & competitive threats 508 13.1.3 THERMO FISHER SCIENTIFIC INC. 509 13.1.3.1 Business overview 509 13.1.3.2 Products/Services offered 510 13.1.3.3 MnM view 517 13.1.3.3.1 Key strengths 517 13.1.3.3.2 Strategic choices 517 13.1.3.3.3 Weaknesses & competitive threats 517 13.1.4 ANTECH DIAGNOSTICS, INC. 518 13.1.4.1 Business overview 518 13.1.4.2 Products/Services offered 518 13.1.4.3 Recent developments 519 13.1.4.3.1 Product/Service launches, enhancements, and approvals 519 13.1.4.3.2 Expansions 520 13.1.4.4 MnM view 520 13.1.4.4.1 Key strengths 520 13.1.4.4.2 Strategic choices 520 13.1.4.4.3 Weaknesses & competitive threats 520 13.1.5 BIOMÉRIEUX 521 13.1.5.1 Business overview 521 13.1.5.2 Products/Services offered 522 13.1.5.3 Recent developments 523 13.1.5.3.1 Product/Service launches, enhancements, and approvals 523 13.1.5.4 MnM view 523 13.1.5.4.1 Key strengths 523 13.1.5.4.2 Strategic choices 523 13.1.5.4.3 Weaknesses & competitive threats 524 13.1.6 NEOGEN CORPORATION 525 13.1.6.1 Business overview 525 13.1.6.2 Products/Services offered 526 13.1.6.3 Recent developments 528 13.1.6.3.1 Product/Service launches, enhancements, and approvals 528 13.1.6.3.2 Deals 529 13.1.6.3.3 Other developments 529 13.1.7 BIO-RAD LABORATORIES, INC. 530 13.1.7.1 Business overview 530 13.1.7.2 Products/Services offered 531   13.1.8 VIRBAC 533 13.1.8.1 Business overview 533 13.1.8.2 Products/Services offered 534 13.1.8.3 Recent developments 535 13.1.8.3.1 Deals 535 13.1.8.3.2 Expansions 536 13.1.9 FUJIFILM HOLDINGS CORPORATION 537 13.1.9.1 Business overview 537 13.1.9.2 Products/Services offered 538 13.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD. 539 13.1.10.1 Business overview 539 13.1.10.2 Products/Services offered 540 13.1.10.3 Recent developments 541 13.1.10.3.1 Product/Service launches, enhancements, and approvals 541 13.1.10.3.2 Expansions 541 13.1.11 INDICAL BIOSCIENCE GMBH 542 13.1.11.1 Business overview 542 13.1.11.2 Products/Services offered 542 13.1.11.3 Recent developments 545 13.1.11.3.1 Product/Service launches, enhancements, and approvals 545 13.1.12 BIONOTE 546 13.1.12.1 Business overview 546 13.1.12.2 Products/Services offered 546 13.1.12.3 Recent developments 549 13.1.12.4 Product/Service launches, enhancements, and approvals 549 13.1.12.4.1 Deals 550 13.1.13 BIOGAL 551 13.1.13.1 Business overview 551 13.1.13.2 Products/Services offered 551 13.1.14 AGROLABO S.P.A. 553 13.1.14.1 Business overview 553 13.1.14.2 Products/Services offered 553 13.1.15 INNOVATIVE DIAGNOSTICS 558 13.1.15.1 Business overview 558 13.1.15.2 Products/Services offered 558 13.2 OTHER PLAYERS 566 13.2.1 RANDOX LABORATORIES LTD. 566 13.2.2 BIOCHEK 567 13.2.3 FASSISI, GMBH 568 13.2.4 ALVEDIA 569 13.2.5 SKYER, INC. 570 13.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY, INC. 571 13.2.7 PRECISION BIOSENSOR, INC. 572 13.2.8 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 573 13.2.9 GOLD STANDARD DIAGNOSTICS 574 13.2.10 SKYLA CORPORATION 575 14 APPENDIX 576 14.1 DISCUSSION GUIDE 576 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 581 14.3 RELATED REPORTS 583 14.4 AUTHOR DETAILS 584
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 48 TABLE 2 VETERINARY DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS 64 TABLE 3 VETERINARY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS 65 TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS) 76 TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023) 79 TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023 81 TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION) 82 TABLE 8 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 93 TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 12 VETERINARY DIAGNOSTICS MARKET: MAJOR PATENTS 99 TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSANDS) 101 TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSANDS) 101 TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 102 TABLE 16 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024 104 TABLE 17 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2022–2024 105 TABLE 18 AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2022–2024 105 TABLE 19 AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION, 2022–2024 105 TABLE 20 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION, 2022–2024 106 TABLE 21 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2022–2024 106 TABLE 22 VETERINARY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 107 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTIC PRODUCTS (%) 108 TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS 112 TABLE 25 VETERINARY DIAGNOSTIC PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM 113 TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES 118 TABLE 27 KEY PRODUCT-RELATED TARIFFS FOR VETERINARY DIAGNOSTICS 119 TABLE 28 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 120 TABLE 29 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 120 TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 121 TABLE 31 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 122 TABLE 32 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 124 TABLE 33 VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 34 KEY PLAYERS OFFERING VETERINARY DIAGNOSTIC CONSUMABLES 126 TABLE 35 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 36 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC INSTRUMENTS 128 TABLE 37 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 38 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 131 TABLE 39 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES 132 TABLE 40 VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 41 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 42 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS 135 TABLE 43 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135 TABLE 44 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 45 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS 137 TABLE 46 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS 139 TABLE 48 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 49 KEY PLAYERS PROVIDING ELISA TESTS 141 TABLE 50 ELISA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 51 KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 143 TABLE 52 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 53 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS 145 TABLE 54 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 55 KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS 147 TABLE 56 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC PRODUCTS 149 TABLE 58 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 59 KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS 151 TABLE 60 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 61 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 62 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS 154 TABLE 63 CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 64 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 65 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES 156 TABLE 66 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 67 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS 158 TABLE 68 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 158 TABLE 69 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 70 KEY PLAYERS PROVIDING GLUCOSE MONITORING 160 TABLE 71 GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 72 GLUCOSE MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 73 KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS 162 TABLE 74 BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 162 TABLE 75 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 76 KEY PLAYERS PROVIDING GLUCOSE MONITORS 164 TABLE 77 GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 164 TABLE 78 GLUCOSE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 79 KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS 166 TABLE 80 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 81 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS 168 TABLE 82 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 83 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 84 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES 170 TABLE 85 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 86 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS 172 TABLE 87 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 172 TABLE 88 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 89 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS 174 TABLE 90 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 91 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 92 KEY PLAYERS PROVIDING PCR TESTS 177 TABLE 93 PCR TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 94 KEY PLAYERS PROVIDING MICROARRAYS 179 TABLE 95 MICROARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 96 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING 181 TABLE 97 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 98 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC PRODUCTS 183 TABLE 99 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 100 KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS 185 TABLE 101 VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 102 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 103 KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES 188 TABLE 104 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 105 KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS 190 TABLE 106 HEMATOLOGY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 190 TABLE 107 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 108 KEY PLAYERS PROVIDING URINALYSIS PRODUCTS 192 TABLE 109 VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 110 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 111 KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES 194 TABLE 112 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 113 KEY PLAYERS PROVIDING URINE ANALYZERS 196 TABLE 114 URINE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 196 TABLE 115 URINE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 116 KEY PLAYERS PROVIDING URINE TEST STRIPS 198 TABLE 117 URINE TEST STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 198 TABLE 118 URINE TEST STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 119 KEY PLAYERS PROVIDING OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES 200 TABLE 120 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 121 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 203 TABLE 122 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR COMPANION ANIMALS 203 TABLE 123 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 124 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 125 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR DOGS 206 TABLE 126 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 127 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATS 208 TABLE 128 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 129 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR HORSES 210 TABLE 130 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 131 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER COMPANION ANIMALS 212 TABLE 132 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 133 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR LIVESTOCK 214 TABLE 134 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 135 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 136 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATTLE 217 TABLE 137 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 138 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PIGS 219 TABLE 139 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 140 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR POULTRY 221 TABLE 141 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 142 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER LIVESTOCK ANIMALS 223 TABLE 143 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 144 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 226 TABLE 145 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR INFECTIOUS DISEASES 227 TABLE 146 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 147 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 148 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR BACTERIAL INFECTIONS 229 TABLE 149 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 150 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR VIRAL INFECTIONS 231 TABLE 151 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 152 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PARASITIC INFECTIONS 233 TABLE 153 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 154 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER INFECTIONS 235 TABLE 155 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 156 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ENDOCRINOLOGY APPLICATIONS 237 TABLE 157 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 158 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CARDIOLOGY APPLICATIONS 239 TABLE 159 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 160 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ONCOLOGY APPLICATIONS 241 TABLE 161 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 162 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER APPLICATIONS 243 TABLE 163 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 164 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 165 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 166 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2023) (USD) 248 TABLE 167 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 168 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 169 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 170 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 255 TABLE 171 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 172 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 258 TABLE 173 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 258 TABLE 174 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 175 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 176 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 177 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 178 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 179 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 180 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 181 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 182 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 183 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 262 TABLE 184 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 185 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 186 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 263 TABLE 187 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 188 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 189 US: KEY MACRO INDICATORS 265 TABLE 190 US: VETERINARY DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 191 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 265 TABLE 192 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 193 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 266 TABLE 194 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 195 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 196 US: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 197 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 198 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 199 US: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 200 US: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 201 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 269 TABLE 202 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 203 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 204 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270 TABLE 205 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 206 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 270 TABLE 207 CANADA: KEY MACRO INDICATORS 271 TABLE 208 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 271 TABLE 209 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 272 TABLE 210 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 211 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 212 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 213 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 214 CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 215 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 216 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 217 CANADA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 218 CANADA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 219 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 275 TABLE 220 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 221 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 222 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 223 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 224 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 225 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 226 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 279 TABLE 227 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 279 TABLE 228 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 229 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 230 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 231 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 232 EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 233 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 234 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 235 EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 236 EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 237 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 283 TABLE 238 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 239 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 240 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 284 TABLE 241 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 242 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 243 GERMANY: KEY MACRO INDICATORS 286 TABLE 244 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 286 TABLE 245 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 286 TABLE 246 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 247 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 248 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 249 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 250 GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 251 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 252 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 253 GERMANY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 254 GERMANY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 255 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 290 TABLE 256 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 257 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 258 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291 TABLE 259 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 260 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 292 TABLE 261 UK: KEY MACRO INDICATORS 293 TABLE 262 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 293 TABLE 263 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 294 TABLE 264 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 265 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 266 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 267 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 268 UK: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 269 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 270 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 271 UK: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 272 UK: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 273 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 297 TABLE 274 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 275 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 276 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 298 TABLE 277 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 278 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 279 FRANCE: KEY MACRO INDICATORS 300 TABLE 280 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 300 TABLE 281 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 300 TABLE 282 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 283 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 284 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 285 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 286 FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 287 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 288 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 289 FRANCE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 290 FRANCE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 291 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 304 TABLE 292 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 293 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 294 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 305 TABLE 295 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 296 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 306 TABLE 297 ITALY: KEY MACRO INDICATORS 307 TABLE 298 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 307 TABLE 299 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 307 TABLE 300 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 301 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 302 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 303 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 304 ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 305 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 306 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 307 ITALY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 308 ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 309 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 311 TABLE 310 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 311 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 312 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 312 TABLE 313 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 314 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 312 TABLE 315 SPAIN: KEY MACRO INDICATORS 313 TABLE 316 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 313 TABLE 317 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 314 TABLE 318 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 319 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 320 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 321 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 322 SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 323 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 324 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 325 SPAIN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 326 SPAIN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 327 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 317 TABLE 328 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 329 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 330 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 318 TABLE 331 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 332 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 319 TABLE 333 NETHERLANDS: KEY MACRO INDICATORS 320 TABLE 334 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 320 TABLE 335 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 321 TABLE 336 NETHERLANDS: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 337 NETHERLANDS: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 338 NETHERLANDS: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 339 NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 340 NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 341 NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 342 NETHERLANDS: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 343 NETHERLANDS: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 344 NETHERLANDS: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 345 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 324 TABLE 346 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 347 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 348 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 325 TABLE 349 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 350 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 326 TABLE 351 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 327 TABLE 352 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 327 TABLE 353 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 354 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 355 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 356 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 357 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 358 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 359 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 360 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 361 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 362 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 331 TABLE 363 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 364 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 365 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 332 TABLE 366 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 367 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 333 TABLE 368 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 336 TABLE 369 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 336 TABLE 370 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 337 TABLE 371 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 372 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 373 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 374 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 375 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 376 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 377 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 378 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 379 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 380 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 340 TABLE 381 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 382 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 383 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 341 TABLE 384 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 385 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 342 TABLE 386 CHINA: KEY MACRO INDICATORS 343 TABLE 387 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 343 TABLE 388 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 344 TABLE 389 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 390 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 391 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 392 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 393 CHINA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 394 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 395 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 396 CHINA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 397 CHINA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 398 CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 347 TABLE 399 CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 400 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 401 CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 348 TABLE 402 CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 403 CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 349 TABLE 404 JAPAN: KEY MACRO INDICATORS 350 TABLE 405 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 351 TABLE 406 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 351 TABLE 407 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 408 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 409 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 410 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 411 JAPAN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 412 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 413 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 414 JAPAN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 415 JAPAN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 416 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 355 TABLE 417 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 418 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 419 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 356 TABLE 420 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 421 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 357 TABLE 422 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 358 TABLE 423 INDIA: KEY MACRO INDICATORS 358 TABLE 424 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 359 TABLE 425 INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 359 TABLE 426 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 427 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 428 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 429 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 430 INDIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 431 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 432 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 433 INDIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 434 INDIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 435 INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 363 TABLE 436 INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 437 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 438 INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 364 TABLE 439 INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 440 INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 365 TABLE 441 AUSTRALIA: KEY MACRO INDICATORS 365 TABLE 442 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 366 TABLE 443 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 366 TABLE 444 AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 445 AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 446 AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 447 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 448 AUSTRALIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 449 AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 450 AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 451 AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 452 AUSTRALIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 453 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 370 TABLE 454 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 455 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 456 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 371 TABLE 457 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 458 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 372 TABLE 459 SOUTH KOREA: KEY MACRO INDICATORS 372 TABLE 460 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 373 TABLE 461 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 373 TABLE 462 SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 463 SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 464 SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 465 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 466 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 467 SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 468 SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 469 SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 470 SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 471 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 377 TABLE 472 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 473 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 474 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 378 TABLE 475 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 476 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 379 TABLE 477 NEW ZEALAND: KEY MACRO INDICATORS 379 TABLE 478 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 380 TABLE 479 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 380 TABLE 480 NEW ZEALAND: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 481 NEW ZEALAND: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 482 NEW ZEALAND: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 483 NEW ZEALAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 484 NEW ZEALAND: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 485 NEW ZEALAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 486 NEW ZEALAND: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 487 NEW ZEALAND: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 488 NEW ZEALAND: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 489 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 384 TABLE 490 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 491 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 492 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 385 TABLE 493 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 494 NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 386 TABLE 495 VIETNAM: KEY MACRO INDICATORS 386 TABLE 496 VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 387 TABLE 497 VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 387 TABLE 498 VIETNAM: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 499 VIETNAM: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 500 VIETNAM: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 501 VIETNAM: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 502 VIETNAM: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 503 VIETNAM: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 504 VIETNAM: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 505 VIETNAM: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 506 VIETNAM: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 507 VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 391 TABLE 508 VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 509 VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 510 VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 392 TABLE 511 VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 512 VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 393 TABLE 513 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 393 TABLE 514 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 394 TABLE 515 REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 516 REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 517 REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 518 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 519 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 520 REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 521 REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 522 REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 523 REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 524 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 397 TABLE 525 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 526 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 527 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 398 TABLE 528 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 529 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 399 TABLE 530 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 400 TABLE 531 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 401 TABLE 532 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 401 TABLE 533 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 534 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 535 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 536 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 537 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 538 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 539 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 540 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 541 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 542 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 405 TABLE 543 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 544 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 545 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 406 TABLE 546 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 547 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 407 TABLE 548 BRAZIL: KEY MACRO INDICATORS 408 TABLE 549 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 408 TABLE 550 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 408 TABLE 551 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 552 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 553 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 554 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 555 BRAZIL: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 556 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 557 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 558 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 559 BRAZIL: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 560 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 412 TABLE 561 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 562 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 563 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 413 TABLE 564 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 565 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 413 TABLE 566 MEXICO: KEY MACRO INDICATORS 414 TABLE 567 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 414 TABLE 568 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030(USD MILLION) 415 TABLE 569 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 415 TABLE 570 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 571 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 572 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 573 MEXICO: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 574 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 575 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 576 MEXICO: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 577 MEXICO: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 578 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 418 TABLE 579 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 580 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 581 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 420 TABLE 582 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 583 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 421 TABLE 584 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 421 TABLE 585 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 422 TABLE 586 REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 587 REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 588 REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 589 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 590 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 591 REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 592 REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 593 REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 594 REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 595 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 425 TABLE 596 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 426 TABLE 597 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 426 TABLE 598 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 427 TABLE 599 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 600 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 428 TABLE 601 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 429 TABLE 602 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 430 TABLE 603 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 430 TABLE 604 MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 431 TABLE 605 MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 431 TABLE 606 MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 607 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 608 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 609 MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 610 MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 611 MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 612 MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 613 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 434 TABLE 614 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 615 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 616 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 435 TABLE 617 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 618 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 436 TABLE 619 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 437 TABLE 620 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 437 TABLE 621 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 438 TABLE 622 GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 438 TABLE 623 GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 624 GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 625 GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 626 GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 440 TABLE 627 GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 440 TABLE 628 GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 440 TABLE 629 GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 630 GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 631 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 441 TABLE 632 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 633 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 634 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 442 TABLE 635 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 636 GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 443 TABLE 637 KINGDOM OF SAUDI ARABIA: KEY MACRO INDICATORS 444 TABLE 638 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 444 TABLE 639 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 444 TABLE 640 KINGDOM OF SAUDI ARABIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 641 KINGDOM OF SAUDI ARABIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 642 KINGDOM OF SAUDI ARABIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 643 KINGDOM OF SAUDI ARABIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 644 KINGDOM OF SAUDI ARABIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 645 KINGDOM OF SAUDI ARABIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 447 TABLE 646 KINGDOM OF SAUDI ARABIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 447 TABLE 647 KINGDOM OF SAUDI ARABIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 447 TABLE 648 KINGDOM OF SAUDI ARABIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 448 TABLE 649 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 448 TABLE 650 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 448 TABLE 651 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 652 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 449 TABLE 653 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 654 KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 450 TABLE 655 UNITED ARAB EMIRATES: KEY MACRO INDICATORS 450 TABLE 656 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 451 TABLE 657 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 451 TABLE 658 UNITED ARAB EMIRATES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 659 UNITED ARAB EMIRATES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 660 UNITED ARAB EMIRATES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 661 UNITED ARAB EMIRATES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 662 UNITED ARAB EMIRATES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 663 UNITED ARAB EMIRATES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 664 UNITED ARAB EMIRATES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 665 UNITED ARAB EMIRATES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 454 TABLE 666 UNITED ARAB EMIRATES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 667 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 455 TABLE 668 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 669 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 670 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 456 TABLE 671 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 672 UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 457 TABLE 673 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 458 TABLE 674 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 458 TABLE 675 OTHER GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 676 OTHER GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 677 OTHER GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 678 OTHER GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 679 OTHER GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 680 OTHER GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 681 OTHER GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 682 OTHER GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 683 OTHER GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 462 TABLE 684 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 462 TABLE 685 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 462 TABLE 686 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 687 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 463 TABLE 688 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 689 OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 464 TABLE 690 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 465 TABLE 691 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 465 TABLE 692 REST OF MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 693 REST OF MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 694 REST OF MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION) 467 TABLE 695 REST OF MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 467 TABLE 696 REST OF MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 467 TABLE 697 REST OF MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 698 REST OF MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 699 REST OF MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 700 REST OF MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 469 TABLE 701 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 469 TABLE 702 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION) 469 TABLE 703 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 704 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 470 TABLE 705 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 706 REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 471 TABLE 707 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET 472 TABLE 708 VETERINARY DIAGNOSTICS MARKET: DEGREE OF COMPETITION 475 TABLE 709 VETERINARY DIAGNOSTICS MARKET: REGION FOOTPRINT 480 TABLE 710 VETERINARY DIAGNOSTIC MARKET: PRODUCT FOOTPRINT 481 TABLE 711 VETERINARY DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT 482 TABLE 712 VETERINARY DIAGNOSTIC MARKET: ANIMAL TYPE FOOTPRINT 483 TABLE 713 VETERINARY DIAGNOSTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES 486 TABLE 714 VETERINARY DIAGNOSTIC MARKET: COMPETITIVE BENCHMARKING OF STARTUPS 487 TABLE 715 VETERINARY DIAGNOSTIC MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 490 TABLE 716 VETERINARY DIAGNOSTICS MARKET: DEALS, JANUARY 2022–MAY 2025 492 TABLE 717 VETERINARY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 492 TABLE 718 VETERINARY DIAGNOSTIC MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025 493 TABLE 719 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 494 TABLE 720 IDEXX LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 495 TABLE 721 IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 500 TABLE 722 ZOETIS SERVICES LLC: COMPANY OVERVIEW 503 TABLE 723 ZOETIS SERVICES LLC: PRODUCTS/SERVICES OFFERED 504 TABLE 724 ZOETIS SERVICES LLC: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 506 TABLE 725 ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025 507 TABLE 726 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025 507 TABLE 727 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 509 TABLE 728 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 510 TABLE 729 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW 518 TABLE 730 ANTECH DIAGNOSTICS, INC.: PRODUCTS/SERVICES OFFERED 518 TABLE 731 ANTECH DIAGNOSTICS, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 519 TABLE 732 ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025 520 TABLE 733 BIOMÉRIEUX: COMPANY OVERVIEW 521 TABLE 734 BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED 522 TABLE 735 BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 523 TABLE 736 NEOGEN CORPORATION: COMPANY OVERVIEW 525 TABLE 737 NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED 526 TABLE 738 NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 528 TABLE 739 NEOGEN CORPORATION: DEALS, JANUARY 2022–MAY 2025 529 TABLE 740 NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 529 TABLE 741 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 530 TABLE 742 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 531 TABLE 743 VIRBAC: COMPANY OVERVIEW 533 TABLE 744 VIRBAC: PRODUCTS/SERVICES OFFERED 534 TABLE 745 VIRBAC: DEALS, JANUARY 2022–MAY 2025 535 TABLE 746 VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025 536 TABLE 747 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 537 TABLE 748 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED 538 TABLE 749 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 539 TABLE 750 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS/SERVICES OFFERED 540 TABLE 751 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 541 TABLE 752 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2022–MAY 2025 541 TABLE 753 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 542 TABLE 754 INDICAL BIOSCIENCE: PRODUCTS/SERVICES OFFERED 542 TABLE 755 INDICAL BIOSCIENCE GMBH: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 545 TABLE 756 BIONOTE: COMPANY OVERVIEW 546 TABLE 757 BIONOTE: PRODUCTS/SERVICES OFFERED 546 TABLE 758 BIONOTE: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 549 TABLE 759 BIONOTE: DEALS, JANUARY 2022–MAY 2025 550 TABLE 760 BIOGAL: COMPANY OVERVIEW 551 TABLE 761 BIOGAL: PRODUCTS/SERVICES OFFERED 551 TABLE 762 AGROLABO S.P.A.: COMPANY OVERVIEW 553 TABLE 763 AGROLABO S.P.A.: PRODUCTS/SERVICES OFFERED 553 TABLE 764 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 558 TABLE 765 INNOVATIVE DIAGNOSTICS: PRODUCTS/SERVICES OFFERED 558 TABLE 766 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 566 TABLE 767 BIOCHEK: COMPANY OVERVIEW 567 TABLE 768 FASSISI, GMBH: COMPANY OVERVIEW 568 TABLE 769 ALVEDIA: COMPANY OVERVIEW 569 TABLE 770 SKYER, INC.: COMPANY OVERVIEW 570 TABLE 771 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 571 TABLE 772 PRECISION BIOSENSOR, INC.: COMPANY OVERVIEW 572 TABLE 773 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW 573 TABLE 774 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 574 TABLE 775 SKYLA CORPORATION: COMPANY OVERVIEW 575 FIGURE 1 VETERINARY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SPREAD 48 FIGURE 2 VETERINARY DIAGNOSTICS MARKET: RESEARCH DESIGN 51 FIGURE 3 PRIMARY SOURCES 53 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 55 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE) 56 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 56 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 57 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 57 FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY DIAGNOSTICS MARKET (2024) 58 FIGURE 10 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS 59 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2025–2030) 60 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 61 FIGURE 13 TOP-DOWN APPROACH 62 FIGURE 14 BOTTOM-UP APPROACH 62 FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY 63 FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 66 FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 67 FIGURE 18 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION) 67 FIGURE 19 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 68 FIGURE 20 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 69 FIGURE 21 GEOGRAPHIC SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET 70 FIGURE 22 GROWING PREVALENCE OF ZOONOTIC DISEASES TO PROPEL MARKET 71 FIGURE 23 CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 72 FIGURE 24 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 73 FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 73 FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 74 FIGURE 27 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75 FIGURE 28 EUROPE: PET POPULATION, 2021–2023 77 FIGURE 29 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD) 81 FIGURE 30 PORTER’S FIVE FORCES ANALYSIS 92 FIGURE 31 VETERINARY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025) 98 FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2014–MAY 2025) 99 FIGURE 33 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY KEY PLAYER, 2024 103 FIGURE 34 AVERAGE SELLING PRICE FOR CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024 104 FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS 108 FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS 109 FIGURE 37 AI-USE CASES 111 FIGURE 38 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 112 FIGURE 39 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 114 FIGURE 40 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 115 FIGURE 41 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS 116 FIGURE 42 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 255 FIGURE 43 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA 256 FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 257 FIGURE 45 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 334 FIGURE 46 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 334 FIGURE 47 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 335 FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2022–2024) 474 FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2024) 475 FIGURE 50 RANKING OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2024 476 FIGURE 51 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2024 478 FIGURE 52 VETERINARY DIAGNOSTICS MARKET: COMPANY FOOTPRINT 479 FIGURE 53 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 485 FIGURE 54 VETERINARY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 488 FIGURE 55 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2022–2024 489 FIGURE 56 EV/EBITDA OF KEY VENDORS 489 FIGURE 57 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 490 FIGURE 58 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 495 FIGURE 59 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024) 504 FIGURE 60 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 510 FIGURE 61 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 522 FIGURE 62 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024) 526 FIGURE 63 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 531 FIGURE 64 VIRBAC: COMPANY SNAPSHOT (2024) 534 FIGURE 65 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024) 538 FIGURE 66 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2024) 540

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們